Long-term outcomes of Ahmed tube implantation in pediatric glaucoma after multiple surgeries

Christiane Al-Haddad1, Khalil Al-Salem2, Karine Ismail3

  • 1Department of Ophthalmology, American University of Beirut Medical Center, Cairo Street, PO Box: 110236, Beirut, Lebanon. ca12@aub.edu.lb.

Insights

Ahmed glaucoma valve (AGV) implantation is successful in pediatric glaucoma patients with prior subconjunctival scarring. This tube shunt surgery effectively lowers intraocular pressure and reduces medication needs, even in complex cases.

Area of Science:

  • Ophthalmology
  • Glaucoma Surgery
  • Pediatric Ophthalmology

Background:

  • Pediatric glaucoma often requires multiple surgical interventions.
  • Subconjunctival scarring from previous surgeries can complicate subsequent glaucoma procedures.
  • Ahmed glaucoma valve (AGV) implantation is a potential option for refractory cases.

Purpose of the Study:

  • To evaluate the efficacy and safety of Ahmed glaucoma valve (AGV) implantation in pediatric glaucoma patients with pre-existing subconjunctival scarring.
  • To determine if prior subconjunctival scarring impacts the success rate of AGV implantation.

Main Methods:

  • Retrospective review of pediatric glaucoma cases undergoing AGV implantation after at least two prior surgeries with conjunctival scarring.
  • Analysis of preoperative and postoperative intraocular pressure (IOP), medication usage, and complications.
  • Success defined as IOP < 22 mmHg without serious complications.

Main Results:

  • Eleven eyes of 10 pediatric patients were analyzed (mean age 12.7 years).
  • Mean preoperative IOP of 24.8 mmHg decreased significantly to 17.5 mmHg postoperatively (p=0.01).
  • Mean anti-glaucoma medication use decreased from 2.8 to 1.4 (p=0.02), with an 82% success rate at 51.6 months follow-up.

Conclusions:

  • Ahmed glaucoma valve (AGV) implantation is a successful surgical option for pediatric glaucoma with subconjunctival scarring.
  • Subconjunctival scarring does not appear to increase the risk of failure for tube shunt surgery in this population.
  • AGV implantation offers significant IOP reduction and decreased medication dependence in complex pediatric glaucoma cases.
Abstract

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.4K
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.5K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K